TheEdgeResearch
Home / Stocks / PCRX

Pacira BioSciences, Inc. (PCRX)

NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
$25.09 ▼ -0.59%
Market Cap
$986.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.29
52-Wk Range
18.8-27.64
CEO
Frank D. Lee
Country
US
Currency
USD

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MV…

Open full interactive analysis & DCF →